| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.686 | 17.369 | 7.552 | 698 | 3.551 | 11.043 | 11.603 | 11.687 | 43.177 | 0 |
| Total Income - EUR | 33.686 | 17.413 | 7.552 | 699 | 3.551 | 11.043 | 11.603 | 11.687 | 43.177 | 0 |
| Total Expenses - EUR | 34.324 | 17.820 | 4.042 | 289 | 16.380 | 24.976 | 10.984 | 17.636 | 16.213 | 12.455 |
| Gross Profit/Loss - EUR | -638 | -406 | 3.510 | 409 | -12.829 | -13.933 | 620 | -5.949 | 26.964 | -12.455 |
| Net Profit/Loss - EUR | -1.648 | -929 | 3.284 | 388 | -12.936 | -14.245 | 272 | -6.300 | 22.736 | -12.455 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Laborator Unteatru S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 16.283 | 14.519 | 17.529 | 16.860 | 17.199 | 17.383 | 2.247 | 2.119 | 9.272 | 9.202 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.169 | 12.433 | 16.031 | 15.910 | 17.170 | 17.351 | 2.119 | 2.125 | 30.105 | 9.211 |
| Cash | 12.113 | 2.086 | 1.498 | 950 | 29 | 31 | 128 | -6 | -20.833 | -9 |
| Shareholders Funds | 14.341 | 13.266 | 16.325 | 16.413 | 3.159 | -11.146 | -10.627 | -16.959 | 5.828 | -6.659 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.942 | 1.253 | 1.204 | 446 | 14.040 | 28.528 | 12.873 | 19.078 | 3.444 | 15.861 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9020 - 9020" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Laborator Unteatru S.r.l.